These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 8916146)

  • 1. Expression of apoptosis, proliferating cell nuclear antigen, and apoptosis-related antigens (bcl-2, c-myc, Fas, Lewis(y) and p53) in human cholangiocarcinomas and hepatocellular carcinomas.
    Terada T; Nakanuma Y
    Pathol Int; 1996 Oct; 46(10):764-70. PubMed ID: 8916146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of apoptosis and expression of apoptosis-related proteins during human intrahepatic bile duct development.
    Terada T; Nakanuma Y
    Am J Pathol; 1995 Jan; 146(1):67-74. PubMed ID: 7531950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Regulation of p53 and bcl-2 proteins to apoptosis and cell proliferation in liver cirrhosis and hepatocellular carcinoma].
    Feng D; Zheng H; Shen M; Cheng R; Yan Y
    Hunan Yi Ke Da Xue Xue Bao; 1999; 24(4):325-8. PubMed ID: 12080637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High levels of BCL-2 messenger RNA detected by in situ hybridization in human hepatocellular and cholangiocellular carcinomas.
    Fiorentino M; D'Errico A; Altimari A; Barozzi C; Grigioni WF
    Diagn Mol Pathol; 1999 Dec; 8(4):189-94. PubMed ID: 10617275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p53 but not bcl-2 is expressed by most cholangiocarcinomas: a study of 28 cases.
    Arora DS; Ramsdale J; Lodge JP; Wyatt JI
    Histopathology; 1999 Jun; 34(6):497-501. PubMed ID: 10383693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human germinal center B cells express the apoptosis-inducing genes Fas, c-myc, P53, and Bax but not the survival gene bcl-2.
    Martinez-Valdez H; Guret C; de Bouteiller O; Fugier I; Banchereau J; Liu YJ
    J Exp Med; 1996 Mar; 183(3):971-7. PubMed ID: 8642300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of antigens related to apoptosis and cell proliferation in chronic nonsuppurative destructive cholangitis in primary biliary cirrhosis.
    Kuroki T; Seki S; Kawakita N; Nakatani K; Hisa T; Kitada T; Sakaguchi H
    Virchows Arch; 1996 Oct; 429(2-3):119-29. PubMed ID: 8917713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative immunohistochemical expression of p63 in human cholangiocarcinoma and hepatocellular carcinoma.
    Ramalho FS; Ramalho LN; Della Porta L; Zucoloto S
    J Gastroenterol Hepatol; 2006 Aug; 21(8):1276-80. PubMed ID: 16872309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulators of apoptosis in cholangiocarcinoma.
    Jhala NC; Vickers SM; Argani P; McDonald JM
    Arch Pathol Lab Med; 2005 Apr; 129(4):481-6. PubMed ID: 15794670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of blood group-related antigens in cholangiocarcinoma in relation to non-neoplastic bile ducts.
    Minato H; Nakanuma Y; Terada T
    Histopathology; 1996 May; 28(5):411-9. PubMed ID: 8735716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of p53 on apoptosis and proliferation of hepatocellular carcinoma cells treated with transcatheter arterial chemoembolization.
    Xiao EH; Li JQ; Huang JF
    World J Gastroenterol; 2004 Jan; 10(2):190-4. PubMed ID: 14716820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of Lewis blood group antigens in cancerous and non-cancerous liver.
    Kanai T; Hirohashi S; Upton MP; Ino Y; Shimosato Y
    Jpn J Cancer Res; 1987 Sep; 78(9):968-76. PubMed ID: 2822639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biliary dysplasia, cell proliferation and nuclear DNA-fragmentation in primary sclerosing cholangitis with and without cholangiocarcinoma.
    Bergquist A; Glaumann H; Stål P; Wang GS; Broomé U
    J Intern Med; 2001 Jan; 249(1):69-75. PubMed ID: 11168786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Overexpression of c-myc and p53 gene in human hepato-cellular carcinoma--a study with immunohistochemistry and in situ hybridization].
    Yang S; Wang M; You W
    Zhonghua Zhong Liu Za Zhi; 1995 Nov; 17(6):415-7. PubMed ID: 8697990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imbalance between cell proliferation and cellular DNA fragmentation in hepatocellular carcinoma.
    Wu PC; Lau VK; Fang JW; Lai VC; Lai CL; Lau JY
    Liver; 1999 Oct; 19(5):444-51. PubMed ID: 10533805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of immunoreactive matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in human normal livers and primary liver tumors.
    Terada T; Okada Y; Nakanuma Y
    Hepatology; 1996 Jun; 23(6):1341-4. PubMed ID: 8675149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of both hepatocellular carcinoma and cholangiocarcinoma phenotypes in hepatocellular carcinoma and cholangiocarcinoma components in combined hepatocellular and cholangiocarcinoma.
    Itoyama M; Hata M; Yamanegi K; Yamada N; Ohyama H; Hirano H; Terada N; Nakasho K
    Med Mol Morphol; 2012 Dec; 45(1):7-13. PubMed ID: 22431178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical detection of bcl-2 protein in normal and pathological human liver.
    Charlotte F; L'Herminé A; Martin N; Geleyn Y; Nollet M; Gaulard P; Zafrani ES
    Am J Pathol; 1994 Mar; 144(3):460-5. PubMed ID: 8129031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of p53 in adenocarcinoma of the gallbladder and bile ducts.
    Washington K; Gottfried MR
    Liver; 1996 Apr; 16(2):99-104. PubMed ID: 8740842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The alphavbeta6 integrin is a highly specific immunohistochemical marker for cholangiocarcinoma.
    Patsenker E; Wilkens L; Banz V; Osterreicher CH; Weimann R; Eisele S; Keogh A; Stroka D; Zimmermann A; Stickel F
    J Hepatol; 2010 Mar; 52(3):362-9. PubMed ID: 20137822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.